Correction: Corrigendum: Nonlinear Growth Kinetics of Breast Cancer Stem Cells: Implications for Cancer Stem Cell Targeted Therapy

Xinfeng Liu, Sara E. Johnson, Shou Liu, Deepak Kanojia, Wei Yue, Udai P. Singh, Qian Wang, Qing Nie, Hexin ChenScientific 2013 · DOI

Abstract

Cancer stem cells (CSCs) have been identified in primary breast cancer tissues and cell lines. The CSC population varies widely among cancerous tissues and cell lines and is often associated with aggressive breast cancers. Despite intensive research, how the CSC population is regulated within a tumor is still not well understood. This study presents a mathematical model to explore the growth kinetics of CSC populations both in vitro and in vivo. The mathematical models and supporting experiments suggest that there exist non-linear growth kinetics of CSCs and negative feedback mechanisms to control the balance between the population of CSCs and that of non-stem cancer cells. The model predictions can help explain several long-standing questions in the field of cancer stem cell research and can be potentially used to predict the efficacy of anti-cancer therapy.

Introduction

Cancer Stem Cells (CSCs) represent a critical subpopulation within tumors, characterized by their ability to self-renew and drive tumor progression. These cells are frequently implicated in treatment resistance and metastasis, making them a primary target for novel therapies. However, a significant hurdle in clinical oncology is the observed heterogeneity of CSC populations; their proportion varies drastically across different breast cancer subtypes and individual patients.

The central challenge addressed in this research is the lack of a mechanistic understanding of how these populations are regulated. Without identifying the biological "thermostat" that controls the CSC population, it remains difficult to design therapies that effectively deplete them. A major concern is that the tumor might simply regenerate lost stem cells from the remaining non-stem population if the underlying regulatory mechanisms are not addressed.

Methodology

To investigate these dynamics, the researchers employed a dual-pronged approach combining theoretical modeling and biological experimentation.

Mathematical Modeling

A system of differential equations was developed to simulate the growth kinetics of CSCs in both in vitro (laboratory cultures) and in vivo (living organism) environments. These models were specifically designed to test for non-linear interactions between CSCs and their progeny, the non-stem cancer cells.

Experimental Validation

Theoretical predictions were rigorously tested against biological data. The study utilized datasets derived from primary breast cancer tissues and established breast cancer cell lines. By comparing model outputs with real-world tumor dynamics, the authors ensured the predictive accuracy of their mathematical framework.

Key Insights: The Mechanics of Tumor Balance

The study revealed two fundamental principles governing breast cancer growth:

  1. Non-linear Growth Kinetics: CSC populations do not expand at a constant, linear rate. Instead, their behavior is highly dependent on the current state and density of the tumor environment. This non-linearity suggests that the "rules" of tumor growth change as the tumor evolves.
  2. Negative Feedback Mechanisms: A critical discovery is the existence of negative feedback loops. It appears that non-stem cancer cells send inhibitory signals that regulate the division and differentiation of CSCs. This feedback maintains a specific equilibrium or "set point" within the tumor.

These findings help explain the observed heterogeneity in clinical settings. The variation between "stem-cell rich" and "stem-cell poor" tumors is likely a result of different set points in these feedback loops across different cancer subtypes.

Results and Therapeutic Implications

The mathematical models successfully matched experimental observations of CSC population shifts, confirming their predictive power.

The most significant implication for therapy is the potential for unintended consequences when targeting only the bulk tumor. The model suggests that therapies which successfully kill non-stem cells might inadvertently weaken the negative feedback signal. This could trigger the remaining CSCs to divide more rapidly or differentiate less, effectively producing more stem cells and leading to treatment resistance or rapid relapse. Consequently, this model serves as a predictive tool to estimate how a tumor will respond to specific anti-cancer interventions, highlighting the need for therapies that account for these feedback loops.

Limitations and Future Directions

While the current model provides a robust framework for understanding cell-to-cell feedback, it does not yet incorporate the full complexity of the tumor microenvironment. Future iterations will need to account for the roles of immune cells, stromal cells, and vascularization. Additionally, further research is required to determine how the mathematical parameters identified in this study can be measured in a clinical setting to guide personalized patient treatment strategies.

Summary updated

Abstract

Cancer stem cells (CSCs) have been identified in primary breast cancer tissues and cell lines. The CSC population varies widely among cancerous tissues and cell lines, and is often associated with aggressive breast cancers. Despite of intensive research, how the CSC population is regulated within a tumor is still not well understood so far. In this paper, we present a mathematical model to explore the growth kinetics of CSC population both in vitro and in vivo. Our mathematical models and supporting experiments suggest that there exist non-linear growth kinetics of CSCs and negative feedback mechanisms to control the balance between the population of CSCs and that of non-stem cancer cells. The model predictions can help us explain a few long-standing questions in the field of cancer stem cell research, and can be potentially used to predict the efficicacy of anti-cancer therapy.
BibTeX
@inproceedings{liu2013correction,
  author = {Xinfeng Liu and Sara E. Johnson and Shou Liu and Deepak Kanojia and Wei Yue and Udai P. Singh and Qian Wang and Qi Wang and Qing Nie and Hexin Chen},
  title = {{Correction: Corrigendum: Nonlinear Growth Kinetics of Breast Cancer Stem Cells: Implications for Cancer Stem Cell Targeted Therapy}},
  booktitle = {Scientific},
  year = {2013},
  doi = {10.1038/srep03173},
}
Figure